The Effects of Particle Size and Molecular Targeting on the Intratumoral and Subcellular Distribution of Polymeric Nanoparticles
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
The current study describes the impact of particle size and/or molecular targeting (epidermal growth factor, EGF) on the in vivo transport of block copolymer micelles (BCMs) in athymic mice bearing human breast cancer xenografts that express differential levels of EGF receptors (EGFR). BCMs with diameters of 25 nm (BCM-25) and 60 nm (BCM-60) were labeled with indium-111 ((111)In) or a fluorescent probe to provide a quantitative and qualitative means of evaluating their whole body, intratumoral, and subcellular distributions. BCM-25 was found to clear rapidly from the plasma compared to BCM-60, leading to an almost 2-fold decrease in their total tumor accumulation. However, the tumoral clearance of BCM-25 was delayed through EGF functionalization, enabling the targeted BCM-25 (T-BCM-25) to achieve a comparable level of total tumor deposition as the nontargeted BCM-60 (NT-BCM-60). Confocal fluorescence microscopy combined with MATLAB analyses revealed that NT-BCM-25 diffuses further away from the blood vessels (D(mean) = 42 +/- 9 microm) following extravasation, compared to NT-BCM-60 which mainly remains in the perivascular regions (D(mean) = 23 +/- 4 microm). The introduction of molecular targeting imposes the "binding site barrier" effect, which retards the tumor penetration of T-BCM-25 (D(mean) = 29 +/- 7 microm, p < 0.05). The intrinsic nuclear translocation property of EGF/EGFR leads to a significant increase in the nuclear uptake of T-BCM-25 in vitro and in vivo via active transport. Overall, these results highlight the need to consider multiple design parameters in the development of nanosystems for delivery of anticancer agents.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In some previous studies, it was shown that sizes from 50 nm–100 nm are effective in preclinical models, suggesting ideal particle size distribution is necessary for efficacy of polymeric micelles [253, 254].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [254]
Citations
Cites
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Drug penetration in solid tumours
Minchinton, A. I., & Tannock, I. F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1893 · Cited by 2,805
Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.
Yuan, F., Dellian, M., Fukumura, D., Leunig, M., Berk, D. A., Torchilin, V. P., & Jain, R. K. (1995) · PubMed · Cited by 1,711
Nano-engineering block copolymer aggregates for drug delivery
Allen, C., Maysinger, D., & Eisenberg, A. (1999) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00058-2 · Cited by 1,358
Self-citationMicellar Nanocontainers Distribute to Defined Cytoplasmic Organelles
Savić, R., Luo, L., Eisenberg, A., & Maysinger, D. (2003) · Science · doi:10.1126/science.1078192 · Cited by 1,113
Sonavane, G., Tomoda, K., & Makino, K. (2008) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2008.07.004 · Cited by 1,100
Nishiyama, N., & Kataoka, K. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.05.006 · Cited by 1,052
Tumor Vascular Permeability, Accumulation, and Penetration of Macromolecular Drug Carriers
Dreher, M. R., Liu, W., Michelich, C. R., Dewhirst, M. W., Yuan, F., & Chilkoti, A. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj070 · Cited by 920
Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms.
Yokota, T., Milenic, D. E., Whitlow, M. D., & Schlom, J. (1992) · PubMed · Cited by 819
Research works printed but not linked: 6
- Yokota T., 1992, Cancer Res., 52, 3402
- Amiji, M. M.Nanotechnology for cancer therapy;CRC/Taylor & Francis:Boca Raton, 2007; p817,[8] of plates.
- Yuan F., 1995, Cancer Res., 55, 3752
- Juweid M., 1992, Cancer Res., 52, 5144
- Thurber G. M., 2008, Trends Pharmacol. Sci., 29, 57
- Costantini D. L., 2008, Cancer Biother. Radiopharm., 23, 3
Cited by
Items 301–348 of 348
Nano-pharmacokinetics: interface of physics, chemistry and biology
Shirsat, S. D., & Mane, R. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85050-6.00005-0 · Cited by 2
Pan, X., Wang, P., Gu, J., Wang, Y., Li, Q., Zhao, W., Wang, S., Gou, J., & Fan, X. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.139275 · Cited by 3
Kumari, N. U., Chigurupati, S. P. D., Rajana, N., Madan, J., & Mehra, N. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33366-8.00013-0 · Cited by 2
Honary, S., & Lavasanifar, A. (2014) · Pharmaceutical Development and Technology · doi:10.3109/10837450.2014.954724 · Cited by 2
Biological barriers to cancer drug delivery, efficacy and cancer models
Madkour, L. H. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-819777-6.00018-4 · Cited by 2
Huang, X., Zhao, B., Yang, Y., Yuan, H., Yao, P., Carlini, R., & Huang, Y. Q. (2023) · Journal of Inorganic and Organometallic Polymers and Materials · doi:10.1007/s10904-023-02830-6 · Cited by 2
Materials-Based Cancer Immunotherapies
Newton, J. M., Sikora, A. G., & Young, S. W. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809880-6.00041-2 · Cited by 3
[Changes in serum parathyroid hormone levels during pregnancy].
Togashi, K., Ishida, O., Yamazaki, M., Jobo, T., & Shimada, N. (1989) · PubMed · Cited by 2
Targeted Drug Delivery in Oncology: Current Paradigm and Challenges
Stirland, D. L., & Bae, Y. H. (2013) · Royal Society of Chemistry eBooks · doi:10.1039/9781849737388-00001 · Cited by 1
The Importance of Particle Geometry in Design of Therapeutic and Imaging Nanovectors
Ware, M. J., Alexander, J. F., Summers, H. D., & Godin, B. (2016) · Advances in delivery science and technology · doi:10.1007/978-1-4939-3634-2_8 · Cited by 1
Environmentally responsive liposomes for treatment of metastatic triple negative breast cancer
Stras, S. (2018) · doi:10.7282/t3r78jnh · Cited by 1
IPN Systems for Cancer Therapy
Jeslin, J., Dhanya, B. S., & Chamundeeswari, M. (2020) · Springer eBooks · doi:10.1007/978-981-15-0283-5_9 · Cited by 1
Targeted nanomedicine delivery to human epidermal growth receptor
Rani, S., Sahoo, R. K., Kumar, V., & Gupta, U. D. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824476-0.00007-3 · Cited by 1
Potential Solutions for Nanotoxicology
Sokouti, B., Bagheri, V., Jahanban‐Esfahlan, A., & Mokhtarzadeh, A. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815079692123010012 · Cited by 1
Lipid nanoparticles loaded with anticancer bioactives: state of the art
Faria, G. N. F., Bhavsar, D., Munshi, A., & Ramesh, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15401-0.00017-8 · Cited by 2
Engineering Fluorescent Nanoparticles for Biomedical Applications
Silvestre, Ó. F., & Chen, X. S. (2013) · Springer eBooks · doi:10.1007/978-1-4471-4372-7_20 · Cited by 1
4.30 Nanomaterials for Drug Delivery to the Brain
Gaudin, A., Seo, Y.-E., Song, E., Quijano, E., King, A. R., & Saltzman, W. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803581-8.09288-2 · Cited by 1
Topical versus systemic antibiotics in the treatment of acute superficial skin infections.
Belcon, M. C. (1979) · PubMed · Cited by 3
Pustulka, K. M. (2012) · University of Minnesota Digital Conservancy (University of Minnesota) · Cited by 2
Responsive Liposomes (for Solid Tumor Therapy)
Sofou, S. (2011) · Wiley eBooks · doi:10.1002/9783527634057.ch30
Sunoqrot, S. (2013) · Figshare
Understanding the Mechanism of Hard Metal (WC-Co) Toxicity: In vitro Studies and In vivo Exploration
Armstead, A. (2014) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.5122
The Study of Non-Viral Nanoscale Delivery Systems for Islet Transplantation
Gutiérrez, D. (2015) · Figshare
Albanese, A. (2014) · TSpace (University of Toronto)
Aresh, W. (2016) · OpenCommons at University of Connecticut (University of Connecticut)
Pharmacokinetics, biodistribution and intratumoral distribution of Celludo nanoparticles
Zhao, Y. (2017) · cIRcle (University of British Columbia) · doi:10.14288/1.0319143
Mikhail, A. S. (2013) · TSpace (University of Toronto)
Hoang, B. (2014) · TSpace (University of Toronto)
Self-citationDesign and Synthesis of Self-Assembled Polymeric Nanoparticles for Cancer Drug Delivery
Logie, J. (2017) · TSpace (University of Toronto)
PLGA-modified nanoparticles for the treatment of hypo-vascularized HPV-related cervical cancers.
Sims, L. B. (2018) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/2892
Micelles: Tumor Imaging and Drug Delivery
Zhao, J., & Li, C. (2015) · Taylor & Francis eBooks · doi:10.1081/e-ebpp-120050393
Insights into Sub-20 nm Nanocarriers (3-helix Micelles) at the Molecular and Cellular Level
Jung, B. T. (2020) · eScholarship (California Digital Library)
Pharmacokinetics/pharmacodynamics and clinical relationship
Kandasamy, G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85050-6.00011-6 · Cited by 2
Zoudani, E. L., Soltani, M., & Raahemifar, K. (2022) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-022-09623-3
Sahovaler, A., Valic, M. S., Townson, J. L., Chan, H. H. L., Zheng, M., Tzelnick, S., Mondello, T., Pener-Tessler, A., Eu, D., El‐Sayes, A., et al. (2024) · doi:10.1158/2767-9764.25417052.v1
Sahovaler, A., Valic, M. S., Townson, J. L., Chan, H. H. L., Zheng, M., Tzelnick, S., Mondello, T., Pener-Tessler, A., Eu, D., El‐Sayes, A., et al. (2024) · doi:10.1158/2767-9764.25417034.v1
Sahovaler, A., Valic, M. S., Townson, J. L., Chan, H. H. L., Zheng, M., Tzelnick, S., Mondello, T., Pener-Tessler, A., Eu, D., El‐Sayes, A., et al. (2024) · doi:10.1158/2767-9764.25417034
Sahovaler, A., Valic, M. S., Townson, J. L., Chan, H. H. L., Zheng, M., Tzelnick, S., Mondello, T., Pener-Tessler, A., Eu, D., El‐Sayes, A., et al. (2024) · doi:10.1158/2767-9764.25417052
Polymer-based nanomedicine against extracellular pathogens
Chowdhury, A., Pal, S., Roy, K., Mazumder, P. M., & Gorain, B. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36388-7.00014-8
Nanoparticules hybrides thermosensibles pour la théranostique
Louguet, S. (2011) · theses.fr (ABES) · doi:10.70675/abb0fe80z7f03z46e0z898bzc619e7281b21
Goodarzi, S. (2021) · theses.fr (ABES) · doi:10.70675/b0a0d503z93b4z464bz93d6z36d6613fb371 · Cited by 1
Aminabee, S., Ogirala, U. R., Shankar, K. R., Kollipara, N. V. C. L., Karnati, S., & Nadh, A. V. S. R. S. (2026) · Biosciences Biotechnology Research Asia · doi:10.13005/bbra/3476
Nanomaterials: An innovative integrative paradigm for hepatocellular carcinoma adjuvant treatment
Yang, Q., Zhang, W., Ji, K., Wang, Z., Gao, J., & Ding, J. (2026) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2026.101151
Nanogels-Mediated Delivery of Vaccines
Halagali, P., Seenivasan, R., Datta, D., Ranade, S. D., & Tippavajhala, V. K. (2026) · Nanomedicine and nanotoxicology · doi:10.1007/978-3-032-29006-9_8
Metadata
- Authors
- Lee, H., Fonge, H., Hoang, B., Reilly, R. M., & Allen, C.
- Affiliations
- University Health Network (CA)
- Corresponding author
- Allen, Christine
- Venue
- Molecular Pharmaceutics
- Publisher
- American Chemical Society (ACS)
- Published
- 2010-05-26
- Volume
- 7
- Issue
- 4
- Pages
- 1195-1208
- ISSN
- 1543-8384 (ISSN-L)
- 1543-8392
- OpenAlex
- W1985006200
- Cited by
- 349
- References
- 46
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 18 · 2023: 15 · 2022: 10 · 2021: 24 · 2020: 35 · 2019: 30 · 2018: 23 · 2017: 35 · 2016: 26 · 2015: 24 · 2014: 28 · 2013: 26 · 2012: 24
- FWCI
- 9.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular Pharmaceutics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Keywords
- polymeric nanoparticles, block copolymer micelles, particle size, molecular targeting, epidermal growth factor, EGFR, intratumoral distribution, subcellular localization, tumor penetration, nuclear translocation, tumor xenografts, breast cancer, indium-111 labeling, nanoparticle clearance
- MeSH terms
- Animals, Breast Neoplasms, Drug Carriers, Epidermal Growth Factor, Female, Humans, Mice, Nude, Particle Size, Polymers, Microscopy, Confocal, Xenograft Model Antitumor Assays, Cell Line, Tumor, Mice, Nanoparticles, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.